Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 5071 AL 5085

Pharmacogenomics of Alzheimer's disease: novel therapeutic strategies for drug development

Cacabelos R, Cacabelos P, Torrellas C, Tellado I, Carril JC.

Methods Mol Biol. 2014;1175:323-556. doi: 10.1007/978-1-4939-0956-8_13.

Clearing the way for tau immunotherapy in Alzheimer's disease

Herrmann A, Spires-Jones T.

J Neurochem. 2015 Jan;132(1):1-4. doi: 10.1111/jnc.12845. Epub 2014 Aug 23.

Overview of immunotherapy in Alzheimer's disease (AD) and mechanisms of IVIG neuroprotection in preclinical models of AD

Counts SE, Lahiri DK.

Curr Alzheimer Res. 2014;11(7):623-5. doi: 10.2174/156720501107140815102453.

Comparing the efficacy and safety of Crocus sativus L. with memantine in patients with moderate to severe Alzheimer's disease: a double-blind randomized clinical trial

Farokhnia M, Shafiee Sabet M, Iranpour N, Gougol A, Yekehtaz H, Alimardani R, Farsad F, Kamalipour M, Akhondzadeh S.

Hum Psychopharmacol. 2014 Jul;29(4):351-9. doi: 10.1002/hup.2412.

SAR studies on carboxylic acid series M(1) selective positive allosteric modulators (PAMs)

Kuduk SD, Beshore DC.

Curr Top Med Chem. 2014;14(15):1738-54. doi: 10.2174/1568026614666140826120224.

Impact of Alzheimer's Disease on Caregiver Questionnaire: internal consistency, convergent validity, and test-retest reliability of a new measure for assessing caregiver burden

Cole JC, Ito D, Chen YJ, Cheng R, Bolognese J, Li-McLeod J.

Health Qual Life Outcomes. 2014 Sep 4;12:114. doi: 10.1186/s12955-014-0114-3.

QT prolongation associated with memantine in Alzheimer's disease

Takehara H, Suzuki Y, Someya T.

Psychiatry Clin Neurosci. 2015 Apr;69(4):239-40. doi: 10.1111/pcn.12236. Epub 2014 Oct 9.

Chitosan as a suitable nanocarrier material for anti-Alzheimer drug delivery

Sarvaiya J, Agrawal YK.

Int J Biol Macromol. 2015 Jan;72:454-65. doi: 10.1016/j.ijbiomac.2014.08.052. Epub 2014 Sep 6.

Transdermal rivastigmine in the treatment of Alzheimer's disease: current and future directions

Amanatkar HR, Grossberg GT.

Expert Rev Neurother. 2014 Oct;14(10):1119-25. doi: 10.1586/14737175.2014.955852. Epub 2014 Sep 9.

Mechanisms of action of phytochemicals from medicinal herbs in the treatment of Alzheimer's disease

Kim MH, Kim SH, Yang WM.

Planta Med. 2014 Oct;80(15):1249-58. doi: 10.1055/s-0034-1383038. Epub 2014 Sep 11.

Non-invasive brain stimulation of the right inferior frontal gyrus may improve attention in early Alzheimer's disease: a pilot study

Eliasova I, Anderkova L, Marecek R, Rektorova I.

J Neurol Sci. 2014 Nov 15;346(1-2):318-22. doi: 10.1016/j.jns.2014.08.036. Epub 2014 Aug 29.

Genetic heterogeneity in Alzheimer disease and implications for treatment strategies

Ringman JM, Goate A, Masters CL, Cairns NJ, Danek A, Graff-Radford N, Ghetti B, Morris JC; Dominantly Inherited Alzheimer Network.

Curr Neurol Neurosci Rep. 2014 Nov;14(11):499. doi: 10.1007/s11910-014-0499-8.

Big data: could it ever cure Alzheimer's disease?

Husain M.

Brain. 2014 Oct;137(Pt 10):2623-4. doi: 10.1093/brain/awu245.

Assay suitability for natural product screening: searching for leads to fight Alzheimer's disease

Vasänge M.

Planta Med. 2014 Sep;80(14):1200-9. doi: 10.1055/s-0034-1383063. Epub 2014 Sep 15.

Strategy to reduce free radical species in Alzheimer's disease: an update of selected antioxidants

Di Domenico F, Barone E, Perluigi M, Butterfield DA.

Expert Rev Neurother. 2015 Jan;15(1):19-40. doi: 10.1586/14737175.2015.955853. Epub 2014 Sep 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias